Lineage Cell Therapeutics (LCTX) Stock Chart & Stock Price History $0.81 +0.11 (+15.37%) Closing price 06/13/2025 04:10 PM EasternExtended Trading$0.81 +0.00 (+0.31%) As of 06/13/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock Lineage Cell Therapeutics Stock Price Performance The Lineage Cell Therapeutics (LCTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 11.84%, with a year-to-date return of 61.29%. In the past month, the stock has increased 76.97%, reflecting recent market activity. As of the latest close, Lineage Cell Therapeutics traded at $0.81 with a market cap of $178.65 million and volume of 4.75 million shares. Five years ago, the stock traded at $1.03, representing a 21.31% decrease over that period. At the time, it had a market cap of $155.07 million and a volume of 1.08 million shares. Receive LCTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lineage Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+12.76%1 Month Performance+76.97%3 Month Performance+55.87%Year-To-Date Performance+61.29%1 Year Performance-11.84%5 Year Performance-21.31% LCTX Stock Chart for Saturday, June, 14, 2025 LCTX Chart by TradingView Lineage Cell Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025$0.70$0.81+15.37%$0.85$0.694.75 million shs$178.65 million06/12/2025$0.70$0.70+0.29%$0.71$0.671.50 million shs$154.85 million06/11/2025$0.75$0.70-5.99%$0.79$0.702.02 million shs$154.40 million06/10/2025$0.72$0.75+3.66%$0.83$0.717.37 million shs$164.24 million06/09/2025$0.68$0.72+6.46%$0.74$0.682.04 million shs$158.44 million06/06/2025$0.66$0.68+2.77%$0.68$0.65874,219 shs$148.83 million06/05/2025$0.66$0.66-0.18%$0.67$0.65840,864 shs$144.82 million06/04/2025$0.68$0.66-2.92%$0.68$0.65683,150 shs$145.08 million06/03/2025$0.67$0.68+1.95%$0.68$0.661.10 million shs$149.45 million06/02/2025$0.66$0.67+0.59%$0.68$0.651.00 million shs$146.58 million Get the Latest News and Ratings for LCTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lineage Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/30/2025$0.69$0.66-3.63%$0.68$0.64951,811 shs$145.72 million05/29/2025$0.65$0.69+5.17%$0.70$0.64737,090 shs$151.21 million05/28/2025$0.68$0.65-4.48%$0.69$0.641.21 million shs$143.78 million05/27/2025$0.70$0.68-2.26%$0.76$0.662.39 million shs$150.53 million05/26/2025$0.70$0.70$0.70$0.602.39 million shs$154.01 million05/23/2025$0.60$0.70+15.58%$0.70$0.602.39 million shs$154.01 million05/22/2025$0.51$0.60+18.27%$0.61$0.502.00 million shs$133.24 million05/21/2025$0.49$0.51+5.25%$0.51$0.48804,110 shs$112.66 million05/20/2025$0.50$0.49-2.37%$0.50$0.49896,136 shs$107.04 million05/19/2025$0.46$0.50+7.43%$0.50$0.45987,100 shs$109.64 million05/16/2025$0.47$0.46-1.59%$0.49$0.46875,733 shs$102.05 million05/15/2025$0.46$0.47+2.73%$0.47$0.45566,208 shs$103.71 million05/14/2025$0.47$0.46-2.55%$0.49$0.46888,337 shs$100.95 million05/13/2025$0.48$0.47-1.90%$0.48$0.451.18 million shs$103.60 million Related Companies Bicara Therapeutics Stock Price Chart Autolus Therapeutics Stock Price Chart Evolus Stock Price Chart Phathom Pharmaceuticals Stock Price Chart ChromaDex Stock Price Chart Stoke Therapeutics Stock Price Chart Upstream Bio Stock Price Chart Taysha Gene Therapies Stock Price Chart Bicycle Therapeutics Stock Price Chart Mind Medicine (MindMed) Stock Price Chart Receive LCTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lineage Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEAMERICAN:LCTX) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredAs Bitcoin supply vanishes, this Trump-aligned token could explodeBitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lineage Cell Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lineage Cell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LCTX Stock Free LCTX Stock Alerts